Intech Investment Management LLC Purchases 56,778 Shares of Tenet Healthcare Corporation $THC

Intech Investment Management LLC grew its holdings in Tenet Healthcare Corporation (NYSE:THC) by 96.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 115,930 shares of the company’s stock after acquiring an additional 56,778 shares during the period. Intech Investment Management LLC’s holdings in Tenet Healthcare were worth $23,038,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Boston Partners boosted its holdings in Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Tenet Healthcare by 8.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares in the last quarter. Eminence Capital LP bought a new stake in Tenet Healthcare during the third quarter worth approximately $225,263,000. Finally, Bank of America Corp DE lifted its stake in shares of Tenet Healthcare by 9.6% in the third quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock worth $218,996,000 after buying an additional 94,903 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Leerink Partners lifted their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. Truist Financial increased their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Wells Fargo & Company cut their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Jefferies Financial Group raised their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average target price of $244.16.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the sale, the executive vice president directly owned 8,012 shares in the company, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 49,517 shares of company stock worth $11,475,161. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Trading Down 4.2%

Shares of THC opened at $173.45 on Friday. The stock’s 50-day moving average price is $190.50 and its 200 day moving average price is $202.06. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The firm has a market capitalization of $14.94 billion, a price-to-earnings ratio of 9.02, a P/E/G ratio of 1.19 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts predict that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.